ArticleBioinformatics advances2026
Omics BioAnalytics: an RShiny application for multimodal biomarker panel discovery and assessment.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Motivation: Machine learning offers a powerful approach for building predictive models from high-dimensional molecular data. Omics technologies such as transcriptomics, proteomics, and metabolomics quantify thousands of molecules simultaneously, providing deep insights into disease biology. Integrating multiple modalities can enhance predictive performance, as shown in histology-omics and holter-omics applications. To support streamlined, reproducible, and user-friendly multimodal analytics, we developed Omics BioAnalytics, an R Shiny platform for unified analysis, integration, and interpretation of diverse omics datasets. Results: Omics BioAnalytics performs late integration using ensembles of elastic net models trained independently on each modality, with predictions averaged across datasets. The platform provides interactive dashboards for metadata exploration, exploratory analyses, differential expression, gene set analysis, and biomarker discovery. Results are visualized through dynamic plots and downloadable reports, ensuring transparent and reproducible workflows. A unique feature is the integrated multimodal Alexa Skill, which enables voice-based querying and rapid visualization. Together, these web and voice-enabled tools offer accessible and reproducible multimodal analytics for biomedical researchers, supporting the discovery of molecular signatures, predictive biomarkers, and therapeutic targets. Availability and implementation: All source code, public datasets, video walkthroughs, and the deployed application are available at: https://github.com/CompBio-Lab/omicsBioAnalytics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.